Elevance Health, Inc. (BMV:ELV)

Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of MXN 1.31 trillion. The enterprise value is 1.74 trillion.

Market Cap	1.31T
Enterprise Value	1.74T

Important Dates

The next estimated earnings date is Thursday, January 22, 2026.

Earnings Date	Jan 22, 2026
Ex-Dividend Date	Sep 10, 2025

Share Statistics

Current Share Class	222.24M
Shares Outstanding	n/a
Shares Change (YoY)	-3.08%
Shares Change (QoQ)	-0.93%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	94.53%
Float	221.72M

Valuation Ratios

The trailing PE ratio is 12.89 and the forward PE ratio is 11.52.

PE Ratio	12.89
Forward PE	11.52
PS Ratio	0.37
PB Ratio	1.62
P/TBV Ratio	17.09
P/FCF Ratio	18.94
P/OCF Ratio	14.52
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.32, with an EV/FCF ratio of 25.25.

EV / Earnings	17.19
EV / Sales	0.48
EV / EBITDA	10.32
EV / EBIT	11.58
EV / FCF	25.25

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.73.

Current Ratio	1.56
Quick Ratio	1.43
Debt / Equity	0.73
Debt / EBITDA	3.52
Debt / FCF	8.52
Interest Coverage	5.90

Financial Efficiency

Return on equity (ROE) is 12.57% and return on invested capital (ROIC) is 6.89%.

Return on Equity (ROE)	12.57%
Return on Assets (ROA)	4.24%
Return on Invested Capital (ROIC)	6.89%
Return on Capital Employed (ROCE)	9.92%
Revenue Per Employee	34.29M
Profits Per Employee	973,967
Employee Count	104,200
Asset Turnover	1.63
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 28.85 billion in taxes.

Income Tax	28.85B
Effective Tax Rate	22.15%

Stock Price Statistics

The stock price has decreased by -27.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-27.30%
50-Day Moving Average	7,155.52
200-Day Moving Average	8,608.70
Relative Strength Index (RSI)	47.01
Average Volume (20 Days)	307

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.34

Income Statement

In the last 12 months, Elevance Health had revenue of MXN 3.57 trillion and earned 101.49 billion in profits. Earnings per share was 447.29.

Revenue	3.57T
Gross Profit	938.42B
Operating Income	148.94B
Pretax Income	130.25B
Net Income	101.49B
EBITDA	163.69B
EBIT	148.94B
Earnings Per Share (EPS)	447.29

Balance Sheet

The company has 664.28 billion in cash and 588.82 billion in debt, giving a net cash position of -429.01 billion.

Cash & Cash Equivalents	664.28B
Total Debt	588.82B
Net Cash	-429.01B
Net Cash Per Share	n/a
Equity (Book Value)	808.56B
Book Value Per Share	3,630.92
Working Capital	420.04B

Cash Flow

In the last 12 months, operating cash flow was 90.10 billion and capital expenditures -21.00 billion, giving a free cash flow of 69.10 billion.

Operating Cash Flow	90.10B
Capital Expenditures	-21.00B
Free Cash Flow	69.10B
FCF Per Share	n/a

Margins

Gross margin is 26.26%, with operating and profit margins of 4.17% and 2.84%.

Gross Margin	26.26%
Operating Margin	4.17%
Pretax Margin	3.64%
Profit Margin	2.84%
EBITDA Margin	4.58%
EBIT Margin	4.17%
FCF Margin	1.93%

Dividends & Yields

This stock pays an annual dividend of 132.19, which amounts to a dividend yield of 2.10%.

Dividend Per Share	132.19
Dividend Yield	2.10%
Dividend Growth (YoY)	14.50%
Years of Dividend Growth	13
Payout Ratio	27.56%
Buyback Yield	3.08%
Shareholder Yield	5.17%
Earnings Yield	7.76%
FCF Yield	5.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5